Hemispheric Raises $52 Million for AI Brain-Diagnosis Tool After Training on 100,000 People
Updated
Updated · WIRED · Jul 15
Hemispheric Raises $52 Million for AI Brain-Diagnosis Tool After Training on 100,000 People
1 articles · Updated · WIRED · Jul 15
Summary
$52 million in new funding will help Hemispheric push an AI system that analyzes brain electrical activity through a 15-minute EEG test to diagnose cognitive disorders without surgery.
100,000 volunteers generated a quarter-million hours of brain data across Asia, Tel Aviv and Boston, giving the startup the dataset it says was needed to train a generalized model despite wide differences in individual brain activity.
The company said the model has already been tested on groups with PTSD, schizophrenia and depression, and is now entering a clinical study aimed at diagnosing and predicting Alzheimer’s.
Early next year, Hemispheric plans to submit its first PTSD-focused product to the FDA, with a public rollout targeted for later in 2027 if regulators clear it.
Founded by former Apple FaceID and Vision Pro co-inventor Gidi Littwin and Hagai Lalazar, the startup will use the cash to expand U.S. hiring, build healthcare and government partnerships, and collect brain data from millions more people.
As AI decodes our brains, how will we protect our innermost thoughts from misuse and commercial exploitation?
Can an algorithm truly objectify mental illness, or will it just replace human subjectivity with hidden algorithmic biases?
If a brain-reading AI continuously learns, how can regulators ensure it remains safe and unbiased after its initial approval?
Hemispheric Raises $52M to Lead AI Brain Diagnostics Revolution: Market Trends, Ethics, and the Future of Neurotechnology
Overview
Hemispheric has secured $52 million in funding, reflecting strong confidence in companies using advanced technology to transform neurological assessment. This investment is expected to speed up Hemispheric’s research and development, helping bring its innovative brain diagnostic tools closer to clinical use and strengthening its position in the competitive neurotechnology sector. The funding comes at a time when the global market for AI brain diagnostics is highly active, with companies like Wavelet Medical also making breakthroughs in monitoring brain activity. Together, these developments highlight rapid progress and growing momentum in AI-powered brain health solutions.